Skip to main content

What the FDA labels say about taking them together

Efbemalenograstim alfa and eflapegrastim

Efbemalenograstim alfa's FDA label of May 19, 2026 names eflapegrastim in its warnings section; the eflapegrastim label PlainMeds reads does not name efbemalenograstim alfa. The efbemalenograstim alfa label: “RYZNEUTA is contraindicated in patients with a history of serious allergic reactions to RYZNEUTA or other rhG-CSF products such as pegfilgrastim, eflapegrastim or filgrastim products.”

Check it at the source: the efbemalenograstim alfa FDA label on DailyMed (effective May 19, 2026); the eflapegrastim FDA label on DailyMed (effective February 18, 2026).

What does the efbemalenograstim alfa label say about eflapegrastim?

Efbemalenograstim alfa label, warnings

RYZNEUTA is contraindicated in patients with a history of serious allergic reactions to RYZNEUTA or other rhG-CSF products such as pegfilgrastim, eflapegrastim or filgrastim products.

Source: FDA drug label (RYZNEUTA), Acrotech Biopharma Inc, effective May 19, 2026 (SPL set 290ed754-758c-9cae-e063-6294a90ae68b), via openFDA; the full label on DailyMed

What does the eflapegrastim label say about efbemalenograstim alfa?

Eflapegrastim's label (effective February 18, 2026) does not name efbemalenograstim alfa in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Rolvedon), Spectrum Pharmaceuticals, Inc., effective February 18, 2026 (SPL set 6e436115-62e7-4729-aeb0-ff78ea685206), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Efbemalenograstim alfa generic labelers
0Eflapegrastim generic labelers
Efbemalenograstim alfaEflapegrastim
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?